Sandra joined Penumbra in 2022, serving as President, Interventional. Sandra has worked in the medical devices space for over 20 years. She most recently served as President of Hospital Patient Monitoring for Philips, and prior to that spent over 10 combined years at Medtronic (previously Covidien and ev3). Sandra started in marketing, then sales before moving to roles with a broader business focus and of successively greater responsibility. Her most recent role at Medtronic was Vice President and General Manager of its Structural Heart Business, a franchise with global revenue of over $1.5B. Sandra holds a Biomedical Computer Engineering Degree with First Class Honors from the University of Technology of Compiegne Engineering in France. Sandra currently serves on the board of Osprey Medical, Inc. (ASX: Osp)